Hurst AL, et al. - Researchers sought to ascertain the total daily dose of continuous infusion of vancomycin (CIV) required to attain therapeutic serum vancomycin concentrations (SVCs) in pediatric patients according to age (≥31 days to <2 years, 2 to <8 years, and 8 to <18 years). They identified CIV as an effective method for attaining a therapeutic SVC in pediatric patients. Compared to older pediatric patients, patients <8 years of age required higher dosing to reach the goal SVCs of 10 to 15 and 15 to 20 μg/mL.